U.S. Bancorp Profit Rises on Lower Expenses

Revenue grew at a quicker pace than expenses in U.S. Bancorp's third quarter as the regional bank reported a 16% increase in profit from a year earlier.

 
Tesla Advances in China, Buying Land Purchase for a Factory

Elon Musk's electric-vehicle maker is speeding up construction of a plant in Shanghai in response to the U.S.-China trade dispute.

 
Tastemade Orders Up $35 Million Funding Round, Aims to Cash In on Data

Tastemade, a Santa Monica, Calif.-based digital-video company that pairs bite-sized videos with audience data, has raised $35 million in its latest funding round, the company said.

 
Uber Proposals Value Company at $120 Billion Ahead of Possible IPO

The ride-hailing company recently received proposals from banks valuing it at as much as $120 billion in an initial public offering that could take place early next year.

 
Goldman Sachs, Morgan Stanley Show Wall Street Charging Ahead

Goldman Sachs and Morgan Stanley both reported sharply higher third-quarter profits Tuesday, wrapping up a week of big-bank earnings reports that reflect the strength of a U.S. economy shrugging off geopolitical turmoil.

 
Netflix Reports Strong User Growth

Netflix exceeded expectations for adding new subscribers during the third quarter, reporting strong user growth in international markets. Shares jumped after-hours.

 
Abbott Laboratories Meets Views, Narrows Outlook

Abbott Laboratories reported a profit for the third quarter of $563 million, or 32 cents a share, down from $603 million, or 34 cents a share, a year earlier

 
Facebook Accused of Failing to Disclose Ad Errors Sooner

Facebook knew of problems with how it measured viewership of video ads for more than a year before it disclosed them in 2016, according to a complaint filed Tuesday by some advertisers.

 
Can U.S.-China Tensions Derail Two Big Deals?

Chinese regulators have yet to give their blessing to two major deals involving U.S. companies. Now would be a bad time for Beijing to arouse more hostility in Washington.

 
Roche Sales Buoyed by New Drugs

Swiss pharmaceuticals giant Roche said that its nine-month group sales rose on year, buoyed by new drugs.

(END) Dow Jones Newswires

October 17, 2018 09:15 ET (13:15 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.